https://www.ajmc.com/view/ai-driven-research-toolkit-links-aging-biology-and-fibrotic-disease
A recent study outlines how artificial intelligence advancements are transforming research and therapeutic strategies for idiopathic pulmonary fibrosis.
aidrivenresearchtoolkitlinks
https://www.amadaamiga.com/group/amada-amiga-group/discussion/4532a125-a133-4a07-8ef7-f2dc24ced9e7
The Impact of Drug Attrition in Clinical Trials The Fibrotic Diseases Treatment Market is a critical and expanding sector of the global healthcare industry,...
the impactclinical trialsdrugattritionfibrotic
https://pubmed.ncbi.nlm.nih.gov/32708589/
Fibrosing diseases are causes of morbidity and mortality around the world, and they are characterized by excessive extracellular matrix (ECM) accumulation. The...
transcription factorscxpotentialserumbiomarker
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.744857/full
Scleroderma, or systemic sclerosis, is a multi-organ connective tissue disease resulting in fibrosis of the skin, heart, and lungs with no effective treatmen...
frontiersperipheralhybridinosantagonist